CoChat

Flavonoid‐mediated presenilin‐1 phosphorylation reduces Alzheimer's disease β‐amyloid production

Open access
Rezai‐Zadeh, Kavon, Douglas Shytle, R., Bai, Yun, Tian, Jun, Hou, Huayan, Mori, Takashi, Zeng, Jin, Obregon, Demian, Town, Terrence, Tan, Jun · 2009 · Journal of Cellular and Molecular Medicine
Cited by 153

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

Glycogen synthase kinase 3 (GSK‐3) dysregulation is implicated in the two Alzheimer's disease (AD) pathological hallmarks: β‐amyloid plaques and neurofibrillary tangles. GSK‐3 inhibitors may abrogate AD pathology by inhibiting amyloidogenic γ‐secretase cleavage of amyloid precursor protein (APP). Here, we report that the citrus bioflavonoid luteolin reduces amyloid‐β (Aβ) peptide generation in both human ‘Swedish’ mutant APP transgene‐bearing neuron‐like cells and primary neurons. We also find that luteolin induces changes consistent with GSK‐3 inhibition that (i) decrease amyloidogenic γ‐secretase APP processing, and (ii) promote presenilin‐1 (PS1) carboxyl‐terminal fragment (CTF) phosphorylation. Importantly, we find GSK‐3α activity is essential for both PS1 CTF phosphorylation and PS1‐APP interaction. As validation of these findings in vivo, we find that luteolin, when applied to the Tg2576 mouse model of AD, decreases soluble Aβ levels, reduces GSK‐3 activity, and disrupts PS1‐APP association. In addition, we find that Tg2576 mice treated with diosmin, a glycoside of a flavonoid structurally similar to luteolin, display significantly reduced Aβ pathology. We suggest that GSK‐3 inhibition is a viable therapeutic approach for AD by impacting PS1 phosphorylation‐dependent regulation of amyloidogenesis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1582-4934.2008.00344.x

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Cited by

See all 153

Metadata

Authors
Rezai‐Zadeh, K., Douglas Shytle, R., Bai, Y., Tian, J., Hou, H., Mori, T., Zeng, J., Obregon, D., Town, T., & Tan, J.
Venue
Journal of Cellular and Molecular Medicine
Publisher
Wiley
Published
2009-03
Volume
13
Issue
3
Pages
574-588
ISSN
  • 1582-1838 (ISSN-L)
  • 1582-4934
OpenAlex
W2039755830
Cited by
153
References
17
FWCI
4.62
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Flavonoid‐mediated presenilin‐1 phosphorylation reduces Alzheimer's disease β‐amyloid production. https://app.cochat.ai/papers/10.1111/j.1582-4934.2008.00344.x
The paper
Rezai‐Zadeh, K., Douglas Shytle, R., Bai, Y., Tian, J., Hou, H., Mori, T., Zeng, J., Obregon, D., Town, T., & Tan, J. (2009). Flavonoid‐mediated presenilin‐1 phosphorylation reduces Alzheimer's disease β‐amyloid production. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/j.1582-4934.2008.00344.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.